| 1. | Buprenorphine Tapering Schedule and Illicit Opioid Use.  |
| | Ling, Walter ; Hillhouse, Maureen ; Domier, Catherine ; Doraimani, Geetha ; Hunter, Jeremy ; Thomas, Christie ; Jenkins, Jessica ; Hasson, Albert ; Annon, Jeffrey J. ; Saxon, Andrew J. ; Selzer, Jeffrey A. ; Boverman, Joshua ; Bilangi, Richard |
| | Addiction 2009;104(2):256-265 [doi: 10.1111/j.1360-0443.2008.02455.x]. |
| | |
| |
| 2. | HIV and HCV Counseling and Education (C&E) Intervention Training Manual, version 3.0.  |
| | Royer, Mark ; Fuller, Bret E. ; Ober, Allison ; Booth, Robert E. |
| | Revised for the NIDA CTN in October 2004 from: Coyle S. NIDA Counseling and Education Intervention Model (NIH Publication No. 93-3580). Bethesda, MD: National Institute on Drug Abuse, 1993.. |
| | |
| |
| 3. | Facilitating Outpatient Treatment Entry Following Detoxification for Injection Drug Use: A Multisite Test of Three Interventions. |
| | Campbell, Barbara K. ; Fuller, Bret E. ; Lee, Eun Sul ; Tillotson, Carrie ; Woelfel, Tiffany ; Jenkins, Lindsay ; Robinson, James A. ; Booth, Robert E. ; McCarty, Dennis |
| | Psychology of Addictive Behaviors 2009;23(2):260-270. [doi: 10.1037/a0014205]. |
| | |
| |
| 4. | Developing the Therapeutic Alliance as a Bridge to Treatment: Training Manual for the Therapeutic Alliance Intervention. |
| | Campbell, Barbara K. |
| | Unpublished manuscript. Manual developed for NIDA's National Drug Abuse Treatment Clinical Trials Network (CTN) Protocol 0017, 2008. |
| | |
| |
| 5. | HIV and HCV Risk Reduction Interventions in Drug Detoxification and Treatment Settings.  |
| | Booth, Robert E. |
| | Presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Quebec City, Canada, June 16-21, 2007. |
| | |
| |
| 6. | HIV and HCV Risk Reduction Interventions in Drug Detoxification and Treatment Settings. |
| | Booth, Robert E. |
| | Presented at the College on Problems of Drug Dependence (CPDD) annual meeting, June 17-22, 2006. |
| | |
| |
| 7. | Suboxone (Buprenorphine/Naloxone) Taper: A Comparison of Taper Schedules. Should I Join?  |
| | NIDA Center for the Clinical Trials Network (NIDA CCTN) |
| | |
| | |
| |